Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phendimetrazine for Cocaine Use Disorder
NCT02233647Phase 1Completed
- Start
- Sep 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Phendimetrazine in cocaine use disorder (CUD). Primary endpoint: Peak Systolic Pressure at 15 months. Started Sep 2014; status: completed.
02
Drugs
Phendimetrazine
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT02233647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02233647.